Gadopentetate Dimeglumine

Gadopentetate Dimeglumine (CAS No.: 86050-77-3) is a synthetic small molecule metal chelate research reagent in the gadolinium based contrast agent class, broadly categorized for bioimaging method development and translational preclinical imaging workflows in life sciences, where it functions as an extracellular paramagnetic probe that shortens proton relaxation behavior in surrounding water and thereby increases magnetic resonance signal contrast for clearer delineation of vasculature, perfused organs, and other non osseous tissues in experimental systems; mechanistically, its activity is driven by physicochemical modulation of T1 dominant relaxation rather than selective receptor agonism or enzyme inhibition, and no definitive high affinity canonical protein target or pathway specific molecular target profile has been established in the same framework used for classical targeted therapeutics, although imaging readouts generated with this agent are routinely integrated with studies of vascular permeability, tissue perfusion, blood tissue barrier integrity, and pathology associated remodeling across oncology, inflammation, neurology, and toxicology models; reported biological observations also include effects on male germ cell compartments under certain exposure conditions in experimental contexts, supporting its relevance for safety pharmacology and reproductive biology investigations; because standardized potency metrics such as IC50 or EC50 are generally not the primary descriptors for this contrast class, in vitro use is typically discussed as concentration dependent signal or relaxivity effects, often explored across micromolar to millimolar experimental ranges depending on instrument settings, matrix composition, and study endpoints, while cell based assays, phantom systems, and animal imaging protocols commonly optimize concentration or dose empirically, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives; in drug discovery environments, this reagent is commonly applied to non invasive longitudinal imaging for pharmacodynamic biomarker development, compound distribution related imaging assessments, and multimodal workflow calibration as a research use material only.